ASN Presidential Address 2013: innovation and individualization--the path forward for nephrology.
作者信息
Molitoris Bruce A
机构信息
Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; andRouderbush Veterans Affairs, Indianapolis, Indiana
出版信息
J Am Soc Nephrol. 2014 May;25(5):893-7. doi: 10.1681/ASN.2014020150. Epub 2014 Mar 27.
Abstract
摘要
相似文献
1
ASN Presidential Address 2013: innovation and individualization--the path forward for nephrology.美国肾脏病学会2013年主席致辞：创新与个体化——肾脏病学的前进之路
J Am Soc Nephrol. 2014 May;25(5):893-7. doi: 10.1681/ASN.2014020150. Epub 2014 Mar 27.
2
ASN Presidential Address 2014: moving past nephrology's midlife crisis.美国肾脏病学会2014年主席致辞：走出肾脏病学的中年危机
J Am Soc Nephrol. 2015 Apr;26(4):791-5. doi: 10.1681/ASN.2014121239. Epub 2015 Jan 29.
3
Towards precision nephrology: the opportunities and challenges of genomic medicine.迈向精准肾脏医学：基因组医学的机遇与挑战。
J Nephrol. 2018 Feb;31(1):47-60. doi: 10.1007/s40620-017-0448-0. Epub 2017 Oct 17.
4
Precision medicine in nephrology.肾脏病学中的精准医学。
Nat Rev Nephrol. 2020 Nov;16(11):615. doi: 10.1038/s41581-020-00360-9.
5
Presidential Address Kidney Week 2019: Winning the War on Kidney Diseases: The Time Is Now.2019 年肾脏周主席演讲：赢得肾脏疾病之战：现在是时候了。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1213-1219. doi: 10.2215/CJN.15011219. Epub 2020 Mar 24.
6
Diagnoses of uncertain significance: kidney genetics in the 21st century.意义未明的诊断：21世纪的肾脏遗传学
Nat Rev Nephrol. 2020 Nov;16(11):616-618. doi: 10.1038/s41581-020-0277-6.
7
Precision medicine in kidney disease: the patient's view.精准医学在肾脏病中的应用：患者的视角。
Nat Rev Nephrol. 2020 Nov;16(11):625-627. doi: 10.1038/s41581-020-0319-0. Epub 2020 Aug 5.
8
[Italian nephrology and the progress of dialysis from its dawn to the present day].
G Ital Nefrol. 2020 Feb 12;37(1):2020-vol1.
9
Time to end the misuse of race in medicine: cases from nephrology.是时候终结医学中对种族的滥用了：肾脏病学案例
BMJ. 2021 Oct 19;375:n2435. doi: 10.1136/bmj.n2435.
10
Kidney tissue engineering for precision medicine.用于精准医学的肾脏组织工程
Nat Rev Nephrol. 2020 Nov;16(11):623-624. doi: 10.1038/s41581-020-00355-6.
引用本文的文献
1
Nephrology research--the past, present and future.肾脏病学研究——过去、现在和未来。
Nat Rev Nephrol. 2015 Nov;11(11):677-87. doi: 10.1038/nrneph.2015.152. Epub 2015 Sep 29.
本文引用的文献
1
Medical costs of CKD in the Medicare population.医疗保险人群中慢性肾脏病的医疗费用。
J Am Soc Nephrol. 2013 Sep;24(9):1478-83. doi: 10.1681/ASN.2012040392. Epub 2013 Aug 1.
2
Recruiting the next generation of nephrologists.招募下一代肾病学家。
Adv Chronic Kidney Dis. 2013 Jul;20(4):326-35. doi: 10.1053/j.ackd.2013.03.004.
3
World incidence of AKI: a meta-analysis.全球急性肾损伤发病率：一项荟萃分析。
Clin J Am Soc Nephrol. 2013 Sep;8(9):1482-93. doi: 10.2215/CJN.00710113. Epub 2013 Jun 6.
4
Lifetime incidence of CKD stages 3-5 in the United States.美国 3-5 期慢性肾脏病的终身发病率。
Am J Kidney Dis. 2013 Aug;62(2):245-52. doi: 10.1053/j.ajkd.2013.03.009. Epub 2013 Apr 6.
5
Why not nephrology? A survey of US internal medicine subspecialty fellows.为何不是肾脏病学？对美国内科亚专科住院医师的调查。
Am J Kidney Dis. 2013 Apr;61(4):540-6. doi: 10.1053/j.ajkd.2012.10.025. Epub 2013 Jan 16.
6
Basic research in nephrology: are we in decline?肾脏病学的基础研究：我们正在衰落吗？
J Am Soc Nephrol. 2012 Oct;23(10):1611-6. doi: 10.1681/ASN.2012060553. Epub 2012 Aug 23.
7
Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).当前慢性肾脏病（CKD）药物研发面临的挑战——确定肾脏进展和过早发生心血管疾病（CVD）的个体化决定因素。
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii81-8. doi: 10.1093/ndt/gfs270. Epub 2012 Jun 25.
8
New era for drug discovery and development in renal disease.肾脏病药物发现和开发的新纪元。
Nat Rev Nephrol. 2011 Jul 5;7(8):469-77. doi: 10.1038/nrneph.2011.84.
9
The future nephrology workforce: will there be one?未来的肾脏病学劳动力：会有吗？
Clin J Am Soc Nephrol. 2011 Jun;6(6):1501-6. doi: 10.2215/CJN.01290211. Epub 2011 May 5.
10
Nephrology: a specialty in need of resuscitation?肾脏病学：一门需要复苏的专业？
Kidney Int. 2009 Sep;76(6):594-6. doi: 10.1038/ki.2008.685. Epub 2009 Jan 28.
Zotero 插件